Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PIRTIK: PMBL® Sublingual Tablets in Reducing Respiratory Tract Infections in Children
NCT07578012Phase 4Recruiting
- Sponsor
- Lallemand Inc.
- Start
- Jun 2026
- Primary completion
- Mar 2027
- Modality
- Microbiome Therapeutics, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of polyvalent mechanical bacterial lysate in respiratory tract infection (RTI), sponsored by Lallemand Inc.. Started Jun 2026; status: recruiting.
02
Drugs
polyvalent mechanical bacterial lysate
03
Conditions
respiratory tract infection (RTI)
Beyond the preview
Go deeper on NCT07578012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07578012.